 |
市場調査レポート
商品コード
1373847
変形性関節症治療の世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年）Global Osteoarthritis Treatment Market Size, Share, Growth Analysis, By Type(Medication, Physical Therapy and Surgical Procedures), By Application(Knee Osteoarthritis, Hip Osteoarthritis) - Industry Forecast 2023-2030 |
||||||
| 変形性関節症治療の世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月11日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の変形性関節症治療の市場規模は、2021年に74億米ドル、2022年に80億3,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に8.5％のCAGRで拡大し、2030年には154億2,000万米ドルに成長する見通しです。
世界の変形性関節症治療市場は、変形性関節症の有病率の上昇、人口の高齢化、効果的な治療オプションに対する需要の増加を背景に、近年大きな成長を遂げています。ヘルスケアの進歩と平均寿命の改善により、変形性関節症にかかりやすい高齢者の割合が大幅に増加しています。その結果、これらの患者の症状を管理し、生活の質を向上させるための革新的かつ効率的な治療オプションに対するニーズが高まっています。さらに、利用可能な治療オプションと早期介入の重要性に関する意識の高まりが、市場の成長をさらに後押ししています。ヘルスケアプロバイダーや組織は、変形性関節症やその危険因子、利用可能な様々な治療方法について患者を教育することに積極的に取り組んでいます。このような意識の高まりが早期診断とタイムリーな治療開始につながっており、変形性関節症治療製品の需要を促進しています。
世界の肥満率の上昇は、変形性関節症の発生増加に大きく寄与しています。肥満が世界的に増加し続けているため、変形性関節症の有病率も増加しています。このような症例の急増は、肥満の人がその状態を効果的に管理するために包括的なアプローチを必要とすることが多いため、治療オプションに対する需要を促進しています。
疾患修飾療法がないことは、変形性関節症治療の分野では依然として大きな課題です。顕著な進歩にもかかわらず、変形性関節症の進行を遅らせたり、元に戻したりすることができる効果的な治療法はまだ不足しています。この限界は、疾患の全体的な管理を妨げ、患者の治療結果に悪影響を及ぼします。
当レポートは、世界の変形性関節症治療市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の変形性関節症治療市場、タイプ別
- 市場概要
- 投薬
- 理学療法、外科処置
世界の変形性関節症治療市場、用途別
- 市場概要
- 変形性膝関節症
- 変形性股関節症
- 手の変形性関節症
- 変形性脊椎関節症
- 変形性肩関節症、足・足首の変形性関節症
世界の変形性関節症治療市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Novartis International AG
- AbbVie Inc
- Sanofi
- Eli Lilly and Company
- Merck & Co., Inc.
- Bayer AG
- Bristol Myers Squibb Company
- Ferring Pharmaceuticals
- Boehringer Ingelheim International GmbH
- Teva Pharmaceutical Industries Ltd.
- Flexion Therapeutics, Inc.
- Bioventus LLC
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Medtronic plc
- Smith &Nephew plc
- DJO Global, Inc.
Global Osteoarthritis Treatment Market size was valued at USD 7.4 billion in 2021 and is poised to grow from USD 8.03 billion in 2022 to USD 15.42 billion by 2030, growing at a CAGR of 8.5% during the forecast period (2023-2030).
The global osteoarthritis treatment market has witnessed significant growth in recent years, driven by the rising prevalence of osteoarthritis, an aging population, and the increasing demand for effective treatment options. With advancements in healthcare and improved life expectancy, the proportion of elderly individuals susceptible to osteoarthritis has risen significantly. As a result, there is a growing need for innovative and efficient treatment options to manage the symptoms and improve the quality of life for these patients. Moreover, the rising awareness about the available treatment options and the importance of early intervention has further propelled the market growth. Healthcare providers and organizations are actively engaged in educating patients about osteoarthritis, its risk factors, and the various treatment modalities available. This increased awareness has led to early diagnosis and timely treatment initiation, driving the demand for osteoarthritis treatment products.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Osteoarthritis Treatment Market Segmental Analysis
Global Osteoarthritis Treatment Market is segmented by type, application, and region. Based on type, the market can be segmented into Medications, Physical Therapy and Surgical Procedures. Based on application, the market is segmented into Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Spine Osteoarthritis, Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Osteoarthritis Treatment Market Dynamics
Drivers of the Global Osteoarthritis Treatment Market
Rising Obesity Rates
The escalating global rates of obesity contribute significantly to the increased occurrence of osteoarthritis. As obesity continues to rise worldwide, there is a growing prevalence of osteoarthritis cases. This surge in cases drives the demand for treatment options as obese individuals often require comprehensive approaches to manage their condition effectively.
Restraints in the Global Osteoarthritis Treatment Market
Lack of Disease-Modifying Therapies
The absence of disease-modifying therapies remains a significant challenge in the field of osteoarthritis treatment. Despite notable advancements, there is still a lack of effective therapies capable of slowing down or reversing the progression of osteoarthritis. This limitation impedes the overall management of the disease and negatively impacts treatment outcomes for patients.
Market Trends of the Global Osteoarthritis Treatment Key
A key market trend in the global Osteoarthritis Treatment market is the growing emphasis on personalized and multimodal approaches to manage the condition. Osteoarthritis is a degenerative joint disease that affects a significant portion of the global population, particularly the elderly. Traditionally, treatment approaches have focused on pain management and symptom relief through nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics. However, there is an increasing recognition that a one-size-fits-all approach may not be effective for all patients.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Osteoarthritis Treatment Market by Type
- Market Overview
- Medication
- Physical Therapy and Surgical Procedures
- Global Osteoarthritis Treatment Market by Application
- Market Overview
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Spine Osteoarthritis
- Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis
- Global Osteoarthritis Treatment Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Flexion Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DJO Global, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
